Skip to main content
Clinical Trials/NCT06519955
NCT06519955
Recruiting
Phase 2

Peri-incisional Local Infiltration to Improve Pain Control After Periacetabular Osteotomy

Michael C Willey1 site in 1 country120 target enrollmentOctober 3, 2024

Overview

Phase
Phase 2
Intervention
Control
Conditions
Hip Dysplasia
Sponsor
Michael C Willey
Enrollment
120
Locations
1
Primary Endpoint
Post-operative pain after periacetabular osteotomy.
Status
Recruiting
Last Updated
15 days ago

Overview

Brief Summary

The goal of this clinical trial is to compare different peri-incisional local infiltrative anesthesia (PLIA) methods in patients ages 13 to 50 undergoing a periacetabular osteotomy (PAO). The main questions to answer here are:

  1. Does PLIA impact post-operative pain after PAO?
  2. Does PLIA impact pain medication usage as measured by morphine equivalent dosing (MED) after PAO?
  3. Does the timing of PLIA administration impact post-operative pain and MED after PAO? Participants will be asked to complete some surveys; demographics survey, General Self-Efficacy Scale (GSE) and the Pain Resilience Scale. All other information will be gathered from the patients medical chart.

Researchers will compare three groups. 1.) Patients who do not receive PLIA. 2.) Patients who receive PLIA after their incision is closed. 3.) Patients who receive PLIA throughout PAO.

Detailed Description

Patients will be approached at their preoperative appointment. This is the only time researchers will conduct study related activities with patients. All other information will be gathered by chart review. Following consent, patients will be asked to complete surveys through REDCap® using a tablet or computer. These include a self-efficacy survey and a grit survey. Patients will then be randomized in a 1:1:1 ratio. 1.) Patients who do not receive PLIA. 2.) Patients who receive PLIA after their incision is closed. 3.) Patients who receive PLIA throughout PAO. Patients will be blinded to which group they are in, meaning they will not know whether they received the injection or not. Patients may ask to be told what study group they were in at their standard-of-care, 3 month follow-up visit. Following surgery, patients in all treatment arms will be provided with the same intravenous (patient-controlled analgesia) and oral pain medications scheduled as needed per standard of care. The research team will review patient medical records to record narcotic use and visual analog scale (VAS) pain scores post-operatively until discharge from the hospital.

Registry
clinicaltrials.gov
Start Date
October 3, 2024
End Date
September 1, 2026
Last Updated
15 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Michael C Willey
Responsible Party
Sponsor Investigator
Principal Investigator

Michael C Willey

Assistant Professor of Orthopedics and Rehabilitation

University of Iowa

Eligibility Criteria

Inclusion Criteria

  • Adolescent or young adult diagnosed with hip dysplasia indicated for PAO at University of Iowa Hospital and Clinics.

Exclusion Criteria

  • Unable to provide informed consent.
  • Pregnant or breast-feeding individuals
  • Prisoner or ward of the state
  • Allergy or medical contradiction to any of the study medications
  • Patients undergoing femoral osteotomy or surgical hip dislocation with PAO will be excluded

Arms & Interventions

Control

No medication administration. Standard of care medications will be offered.

Post Closure

Once the fascia has been closed, the PLIA will be administered using a pediatric catheter.

Intervention: Ropivacaine, Epinephrine, Ketorolac, NaCl (Saline)

Throughout Procedure

The injection will be performed throughout the surgical procedure.

Intervention: Ropivacaine, Epinephrine, Ketorolac, NaCl (Saline)

Outcomes

Primary Outcomes

Post-operative pain after periacetabular osteotomy.

Time Frame: Post Anesthesia Care Unit (PACU), 24 hours post op

Severity of pain will be measured by collection of the visual analog scale (VAS) for pain. Scale of 1-10.

Pain medication usage after periacetabular osteotomy.

Time Frame: Post Anesthesia Care Unit (PACU) to end of hospital stay, an average of 3 days.

The amount of pain medications taken will be measured using morphine equivalent dosing (MED).

The impact of timing of PLIA administration on post-operative pain.

Time Frame: Post Anesthesia Care Unit (PACU) to end of hospital stay, an average of 3 days.

The mean VAS pain will be compared between the different study groups. Scale of 1-10.

The impact of timing of PLIA administration on MED.

Time Frame: Post Anesthesia Care Unit (PACU) to end of hospital stay, an average of 3 days.

The mean MED will be compared between the different study groups.

Secondary Outcomes

  • Assessment on depression (PHQ-9)(Preoperative)
  • General Self-Efficacy Scale (GSE)(Preoperative)
  • Pain Resilience Scale.(Preoperative)

Study Sites (1)

Loading locations...

Similar Trials